unable to achieve the goal LDL a combination product such as a statin plus

Unable to achieve the goal ldl a combination product

This preview shows page 3 out of 3 pages.

unable to achieve the goal LDL, a combination product such as a statin plus ezetimibe is recommended. The maximum recommended dose is 80 mg daily, so increasing the dose to 80 mg twice daily is incorrect. DIF: Cognitive Level: Applying (Application) REF: 296 7.A patient who has type 2 diabetes mellitus will begin taking a bile acid sequestrant. Which bile acid sequestrant should the primary care NP order? a.Colesevelam (Welchol)b.Colestipol (Colestid)c.Cholestyramine (Questran)d.Cholestyramine (Questran Light)ANS: A All bile acid sequestrants are equally effective. Colesevelam has an additional indication to improve glycemic control in adults with type 2 diabetes and so should be selected when prescribing a bile acid sequestrant for this patient. DIF: Cognitive Level: Applying (Application) REF: 298 8.A patient with primary hypercholesterolemia is taking an HMG-CoA reductase inhibitor. All of the patient’s baseline LFTs were normal. At a 6-month follow-up visit, the patient reports occasional headache. A lipid profile reveals a decrease of 20% in the patient’s LDL cholesterol. The NP should: LFTs should be performed at baseline, 12 weeks after initiation of therapy, and only periodically thereafter. Headaches are common side effects, but do not raise concern about hepatotoxicity. CK-MM tests are indicated if patients report muscle pain or weakness. It is not necessary to decrease the medication. DIF: Cognitive Level: Applying (Application) REF: 299
Image of page 3

You've reached the end of your free preview.

Want to read all 3 pages?

  • Fall '15
  • Cognitive Level, Statin, primary care NP

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture